Media-OutReach Newswire Prudential expands preferred healthcare network in partnership with Icon Cancer Centre
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire Elevating Cancer Care: Thomson Hospital and OncoCare Medical Malaysia Announce Strategic Alliance for Excellence in Oncology
Media-OutReach Newswire HKU AIDS Institute & Immuno Cure’s Collaborative Therapeutic HIV Vaccine Research Project secured HK$66.7m TRS funding from Research Grant Council
Media-OutReach Newswire Immuno Cure’s Anti-Δ42PD1 Antibody Project Awarded HKSAR Government’s RAISe+ Scheme Funding
Media-OutReach Newswire The 7th AIDS Forum of Beijing, Hong Kong, Macau & Taiwan connects medical expertise from different regions
Media-OutReach Newswire CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Media-OutReach Newswire Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
Media-OutReach Newswire Prenetics Acquires ACT Genomics First M&A Deal since IPO Set to Expand Footprint in Cancer Genomics
Media-OutReach Newswire ACT Genomics Hong Kong Laboratory Earns CAP Accreditation NGS Testing and R&D Capacity Strengthened